Danielle M. Bello - Concepedia

Author

Danielle M. Bello

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

D M Bello, D.M. Bello, Daniel Bello, Danielle Bello, Danielle M Bello, Danielle M. Bello, Georgia Beasley

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University

About

Danielle M. Bello is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	360
2	Health Sciences	2	2	62
3	Immunology	2	2	44
4	Cell Biology	1	1	26
5	Pathology	1	1	26

Danielle M. Bello

Publications

895

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant relatlimab and nivolumab in resectable melanoma Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton, Nature	2022	312
Prognosis of Acral Melanoma: A Series of 281 Patients Danielle M. Bello, Joanne F. Chou, Katherine S. Panageas, Annals of Surgical Oncology Acral MelanomaMedicineMelanomaDermatologyOncology	2013	151
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade Charlotte E. Ariyan, Mary Sue Brady, Robert H. Siegelbaum, Cancer Immunology Research	2018	118
Anal Versus Rectal Melanoma Danielle M. Bello, Elizabeth Smyth, Daniel Pérez, Diseases of the Colon & Rectum	2013	72
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade Danielle M. Bello, Katherine S. Panageas, Travis J. Hollmann, Annals of Surgical Oncology Surgical OncologySurvival OutcomesMedicineMelanomaImmune Checkpoint Inhibitor	2019	56
Locoregional Lymphadenectomy in the Surgical Management of Anorectal Melanoma Daniel Pérez, Atthaphorn Trakarnsanga, Jinru Shia, Annals of Surgical Oncology Surgical OncologyMedicineVisceral SurgerySurgeryLymphatic Disease	2013	50
The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma Danielle M. Bello, Gang Han, Laura Jackson, Annals of Surgical Oncology Surgical OncologySkin CancerMedicineMelanomaThick Melanoma	2016	33
Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody. Katja Schindler, Kaan Harmankaya, Michael A. Postow, Journal of Clinical Oncology ImmunodeficienciesImmunologyImmunoeditingImmunotherapeuticsEosinophilic Disorder	2013	29
Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology Danielle M. Bello, Christy Russell, Debbie McCullough, Annals of Surgical Oncology Tumor BiologyPredict Tumor BiologyBreast OncologyMedicinePathology	2018	26
Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma Edmund K. Bartlett, Ann Y. Lee, Philip M. Spanheimer, British journal of surgery	2020	19

Page 1